Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antozzi

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Myasthenia gravis and myasthenic syndromeC Antozzi
Cardiovascular Research|August 1, 1997
Cardiomyopathies in disorders of oxidative metabolismC Antozzi, M Zeviani
Molecular Human Reproduction|February 1, 1997
Mitochondrial disordersM Zeviani, C Antozzi
Brain Pathology (Zurich, Switzerland)|April 1, 1992
Defects of mitochondrial DNAM Zeviani, C Antozzi
Journal of Neurosurgical Anesthesiology|July 1, 1995
Upper motor neuron dysfunction reduces the EMG evidence of myasthenia gravisF Fiacchino, V Scaioli, C Antozzi, et al.
European Neurology|January 1, 1997
Emerging treatments in myopathiesC Antozzi, P Confalonieri, R Mantegazza, et al.
Journal of Neurology|November 1, 1988
Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravisR Mantegazza, C Antozzi, D Peluchetti, et al.
Journal of the Neurological Sciences|September 1, 1991
Riboflavin responsive multiple acyl-CoA dehydrogenase deficiency: functional evaluation of recovery after high dose vitamin supplementationD Peluchetti, C Antozzi, S Roi, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Plasma treatment in diseases of the neuromuscular junctionF Cornelio, C Antozzi, P Confalonieri, et al.
Journal of Neuroimmunology|October 1, 1993
Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serumP Confalonieri, C Antozzi, F Cornelio, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Myasthenia gravis and myasthenic syndromeC Antozzi
Cardiovascular Research|August 1, 1997
Cardiomyopathies in disorders of oxidative metabolismC Antozzi, M Zeviani
Molecular Human Reproduction|February 1, 1997
Mitochondrial disordersM Zeviani, C Antozzi
Brain Pathology (Zurich, Switzerland)|April 1, 1992
Defects of mitochondrial DNAM Zeviani, C Antozzi
Journal of Neurosurgical Anesthesiology|July 1, 1995
Upper motor neuron dysfunction reduces the EMG evidence of myasthenia gravisF Fiacchino, V Scaioli, C Antozzi, et al.
European Neurology|January 1, 1997
Emerging treatments in myopathiesC Antozzi, P Confalonieri, R Mantegazza, et al.
Journal of Neurology|November 1, 1988
Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravisR Mantegazza, C Antozzi, D Peluchetti, et al.
Journal of the Neurological Sciences|September 1, 1991
Riboflavin responsive multiple acyl-CoA dehydrogenase deficiency: functional evaluation of recovery after high dose vitamin supplementationD Peluchetti, C Antozzi, S Roi, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Plasma treatment in diseases of the neuromuscular junctionF Cornelio, C Antozzi, P Confalonieri, et al.
Journal of Neuroimmunology|October 1, 1993
Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serumP Confalonieri, C Antozzi, F Cornelio, et al.
Pageof 6